Remus Pharmaceuticals Limited (NSE:REMUS)

Remus Pharmaceuticals Revenue

Remus Pharmaceuticals had revenue of 4.53B INR in the half year ending March 31, 2026, with 146.57% growth. This brings the company's total for the last twelve months to 10.69B, up 42.89% year-over-year. In the fiscal year ending March 31, 2026, Remus Pharmaceuticals had annual revenue of 8.54B with 37.60% growth. That makes Remus Pharmaceuticals the 21,687th largest company in the world by revenue and 1,287th in India.

• Revenue (ttm): 10.69B
• Revenue Growth: +42.89%
• P/S Ratio: 0.90
• Revenue / Employee: 154.89M
• Employees: 69
• Market Cap: 9.47B

Revenue Chart

Chart

Chart

Revenue by Geography

Chart

• India 3.25B 38.1%
• Asia 2.44B 28.5%
• North America 1.44B 16.9%
• Latin America and The Caribbean 878.40M 10.3%
• Europe 470.00M 5.5%
• Middle East 41.80M 0.5%
• Oceania 14.40M 0.2%
• Africa 4.20M 0.0%

Fiscal year ended Mar 31, 2026 See the full Remus Pharmaceuticals breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2026	8.54B	2.33B	37.60%
Mar 31, 2025	6.20B	4.07B	191.33%
Mar 31, 2024	2.13B	1.68B	371.81%
Mar 31, 2023	451.32M	204.15M	82.59%
Mar 31, 2022	247.17M	59.09M	31.42%

Data Source: S&P Global Market Intelligence Last updated: Sep 8, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Nov 11, 2026

Data Sources Report a data error